Your browser doesn't support javascript.
Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era.
Nakshbandi, Gizal; Moor, Catharina C; Johannson, Kerri A; Maher, Toby M; Kreuter, Michael; Wijsenbeek, Marlies S.
  • Nakshbandi G; Dept of Respiratory Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Moor CC; Dept of Respiratory Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Johannson KA; Dept of Medicine, University of Calgary, Calgary, Canada.
  • Maher TM; Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
  • Kreuter M; Center for Interstitial and Rare Lung Diseases, Thoraxklinik, University of Heidelberg, Germany and German Center for Lung Research, Heidelberg, Germany.
  • Wijsenbeek MS; Dept of Respiratory Medicine, Erasmus University Medical Centre, Rotterdam, The Netherlands.
ERJ Open Res ; 7(3)2021 Jul.
Article in English | MEDLINE | ID: covidwho-1394412
ABSTRACT
The #COVID19 pandemic has led to an increase in the use of eHealth for patients with interstitial lung disease. Healthcare providers worldwide are positive towards further implementation of eHealth for research and clinical practice. https//bit.ly/3h2545M.
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Qualitative research Language: English Year: 2021 Document Type: Article Affiliation country: 23120541.00405-2021

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Qualitative research Language: English Year: 2021 Document Type: Article Affiliation country: 23120541.00405-2021